Commentary|Podcasts|October 7, 2026

Show Me Your Care Plan!™ Navigating ADC Therapies: Oncology Nursing Strategies for Optimal Patient Management

Non-CME PER® Podcast

Thanks for your interest in this podcast. Please read this important program information before listening.

Episode Description

In this podcast, experts Emely Alfaro, DNP, RN, CNS, OCN, Marianne Davies, NP, DNP, MSN, APRN, BSN, and Stephanie McDonald, MSN, FNP-BC, AOCNP, discuss how to recognize, grade, and manage antibody-drug conjugate-associated toxicities.

Acknowledgment of Educational Grant Support

This activity is supported by an educational grant from Merck & Co, Inc.

Emely Alfaro, DNP, RN, CNS, OCN

Clinical Nurse Specialist, Adult Infusion Services
Assistant Clinical Professor
UCSF Health
UCSF School of Nursing
San Francisco, CA

Emely Alfaro, DNP, RN, CNS, OCN, has no relevant financial relationships with ineligible companies.

Marianne Davies, NP, DNP, MSN, APRN, BSN

Oncology Nurse Practitioner
Center for Thoracic Cancers
Yale Medicine
Yale New Haven Health System
New Haven, CT

Marianne Davies, NP, DNP, MSN, APRN, BSN, has no relevant financial relationships with ineligible companies.

Stephanie McDonald, MSN, FNP-BC, AOCNP

Nurse Practitioner
Department of Thoracic Oncology
Dana-Farber Cancer Institute
Boston, MA

Stephanie McDonald, MSN, FNP-BC, AOCNP, has no relevant financial relationships with ineligible companies.

This podcast, including the narration, was developed by PER® editorial staff based on an online activity developed with these faculty. The narration was voiced by a PER staff member or by an AI tool.

To learn more about this topic, including a discussion of antibody-drug conjugate-specific indications and efficacy, go to https://www.gotoper.com/courses/show-me-your-care-plan-navigating-adc-therapies-oncology-nursing-strategies-for-optimal-patient-management-full.

Release Date

October 7, 2026

Expiration Date

October 7, 2027

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this activity is for education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Related to this article